Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

cse:abrt

POPULAR ARTICLES

CSE Bulletin: Reinstatement - Albert Labs International Corp.

CSE Bulletin: Reinstatement - Albert Labs International Corp.

Canadian Investment Regulatory Organization Trade Resumption - ABRT

Canadian Investment Regulatory Organization Trade Resumption - ABRT

CSE Bulletin: Suspensions - ADMT, ABRT, CFT, GAIA, IWIN, PKG, POLE, PRTI, RWB, CALM, RVR, VEJI

psychedelics-investing

CSE Bulletin: Suspensions - ADMT, ABRT, CFT, GAIA, IWIN, PKG, POLE, PRTI, RWB, CALM, RVR, VEJI

LATEST ARTICLES

Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology

psychedelics-investing

Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology

Albert Labs

Albert Labs

psychedelics-investing

Albert Labs Announces Expansion of Drug Discovery and a Promising Pipeline

Albert Labs - CEO and Chairman Dr. Michael Raymont

psychedelics-investing

Albert Labs Eyes One Dose Psilocybin Treatment for Cancer-related Anxiety

Albert Labs announces Private Placement - April 24, 2023

psychedelics-investing

Albert Labs announces Private Placement - April 24, 2023

Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human Trials

psychedelics-investing

Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human Trials

Albert Labs Validates Global Supply Chain for Controlled Substances

psychedelics-investing

Albert Labs Validates Global Supply Chain for Controlled Substances

Albert Labs

Albert Labs

psychedelics-investing

Albert Labs Recognition of the TGA's Rescheduling of Psilocybin

Albert Labs

Albert Labs

psychedelics-investing

Albert Labs Announces Private Placement - February 13, 2023

Albert Labs

Albert Labs

psychedelics-investing

Albert Labs Announces Private Placement

Albert Labs signs Letter of Intent with iNGEN? CRO for First In-Human Clinical Studies

pharmaceutical-investing

Albert Labs signs Letter of Intent with iNGEN? CRO for First In-Human Clinical Studies

Albert Labs provides Corporate Update

pharmaceutical-investing

Albert Labs provides Corporate Update

Albert Labs Files New International PCT Patent Application for scalable API manufacturing

pharmaceutical-investing

Albert Labs Files New International PCT Patent Application for scalable API manufacturing

Latest News

Lucid Announces Upcoming Investor Day

Boralex will release its 2025 fourth quarter financial results on February 27, at 11 a.m.

BD to Announce Financial Results for its First Quarter of Fiscal 2026

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

New Found Gold

New Found Gold (NFG:CC)

NFG:CC

Coelacanth Energy

Coelacanth Energy (CEI:CC)

CEI:CC

One Bullion: Advancing District-scale Gold Assets Across Botswana’s Greenstone Belts

OBUL:CC

Canada One Mining

Canada One Mining (CONE:CC)

CONE:CC

One Bullion Limited

One Bullion Limited (OBUL:CC)

OBUL:CC

ILC Critical Minerals

ILC Critical Minerals (ILC:CC)

ILC:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES